Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CVS Health
Pharma
CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo
In its recommendation, the CDC noted that Gilead's twice-yearly HIV PrEP Yeztugo could "improve PrEP adherence and thus enhance HIV prevention."
Zoey Becker
Sep 19, 2025 11:22am
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
CVS Health returns BMS, Pfizer's Eliquis to formulary
Jun 24, 2022 8:29am
Definitive Healthcare launches data-driven podcast
Jun 21, 2022 9:34am
